Skip to content

Public FDA record

Z-0354-2022: SuperCore Biopsy Instrument: REF/Product Description: 701114090/SUPERCORE BIOPSY INSTR 14GA X 9CM; 70111

Recall record Z-0354-2022 for Argon Medical Devices, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0354-2022
Company in FDA record
Argon Medical Devices, Inc
FDA record creation date
Dec 9, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to component (housing and plunger) detaching from the semi-automatic biopsy instruments.

Source facts

Action
On 09/30/2021, the firm sent an "Urgent-Product Recall Notice" letter to customers via US Postal Service Registered Mail informing them that the firm has received complaints regarding the semi-automatic Biopsy instrument coming apart during shipping or prior to use. According to the firm's investigation, the plastic housing and plunger can be separated more easily than normal for the lots manufactured during this time frame. Customers are instructed to return all affected product to the Recalling Firm's Athens TX facility using RGA#26683, attention Andrea Wieczor. Mailing address is: RGA# 26683 Argon Medical Devices, Inc. 1445 Flat Creek Road Athens, TX 75751 USA Att: Andrea Wieczor In addition, Customers are instructed to complete the response acknowledgement form included with the letter/email and return by fax, mail, or email as soon as possible. For questions. contact the Director, Post-Market Experience at email address Brian.Rogers@argonmedical.com, or contact Arbee Cummings at Arbee.Cummings@argonmedical.com or Andrea Wieczor at Andrea.Wieczor@argonmedical.com. (Updated information 11/2/2021), on 10/28/2021, the firm sent an updated "Urgent-Product Recall Notice for Additional Lots" letter via mail informing customers that they are expanding the recall to additional lots (list on the Inventory Sheet attached to recall notice). Again the Recalling Firm is instructing customer to return the affected product (listed on the Inventory Sheet).
Initiated
2021-10-04
Root cause
Device Design
Distribution
Worldwide distribution - U.S. Nationwide distribution in the states of AK, AL, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, and WV. The countries of ALB, ARE, ARG, AUS, AUT, BEL, BGD, BRA, CAN, CHE, CHL, CHN, COL, CZE, DEU, ECU, ESP, EST, FRA, GBR, GRC, HKG, HUN, IND, IRN, ISR, ITA, JOR, JPN, MAR, MEX, MYS, NLD, NPL, NZL, PAK, PER, PHL, POL, PRT, SAU, SGP, SRB, THA, TUR, and TWN.
Recall number
Z-0354-2022
Recall status
Open, Classified
CDRH record ID
189610
FDA record created
2021-12-09
Recall event number
88814

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗